PICASO vs. COSMAX

PICASO vs. COSMAX at a Glance

Where PICASO Has the Clearer Fit

Where COSMAX Has the Clearer Fit

When Both Companies Deserve a Full Evaluation

The published differences help create a shortlist, but they do not replace a project-specific proposal. PICASO and COSMAX should both be evaluated when the project involves a proprietary formula, an unfamiliar package format, a regulated claim, several shades, or a launch plan that could move from a small opening order to materially larger production.

U.S. Compliance Questions to Resolve Before Signing

For products sold in the United States, the manufacturer’s certifications are only part of the compliance picture. Under MoCRA, manufacturers and processors generally have facility-registration obligations, while the responsible person must handle product listings and maintain adequate safety-substantiation records, subject to applicable exemptions.

• Which legal entity and facility will manufacture and fill the product?
• Is that facility registered as required, and can it provide the information needed for product listing?
• Who will be named on the U.S. label as the responsible person?
• Which party will maintain the safety substantiation file?
• Does the formula contain color additives or claims that could change the regulatory pathway?
• Who reviews the ingredient list, warnings, net contents, business address, and marketing claims?

Send the Same RFQ to PICASO and COSMAX

A fair comparison starts with an identical brief. If each manufacturer receives different volume assumptions, claims, packaging requirements, or launch dates, the resulting quotes will not reveal which partner is actually the better fit.

1. Define the product. Specify category, texture, target consumer, benchmark products, excluded ingredients, desired claims, and target retail price.
2. State the launch markets. Identify the United States and every planned expansion market so the proposal can account for formula, labeling, testing, and documentation requirements.
3. Request quantity tiers. Ask for MOQ, pilot or startup options, and pricing at the opening order, 10,000 units, 50,000 units, and the realistic second-year volume.
4. Separate development from production. Request itemized formula-development, testing, packaging, tooling, regulatory-support, manufacturing, freight, and warehousing costs.
5. Clarify ownership. Ask who owns the formula, testing data, artwork, molds, and any custom ingredient or delivery-system work.
6. Confirm the operating team. Identify the account lead, working language, response-time expectations, sample-review process, and escalation path.

Final Recommendation

Shortlist PICASO first when the brief centers on Japanese cosmetic development, differentiated skincare, efficacy or safety evaluation, quasi-drug experience, or a launch quantity that aligns with its published 3,000-to-5,000-unit starting range.

Shortlist COSMAX first when the business case depends on a U.S. manufacturing option, international production coverage, broad supply-chain access, or support extending from ODM into OBM.

Keep both in the process when formula uniqueness, packaging, regulatory support, communication quality, lead time, and total landed cost matter more than company size or country of origin. A matched RFQ and sample-development round will provide a more reliable answer than a company-profile comparison alone.